Outset Medical
156 hedge funds and large institutions have $2.24B invested in Outset Medical in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 18 closing their positions.
343% more call options, than puts
Call options by funds: $8.38M | Put options by funds: $1.89M
89% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 18
85% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 33
10% more funds holding
Funds holding: 142 → 156 (+14)
0.42% less ownership
Funds ownership: 7.3% → 6.88% (-0.42%)
11% less capital invested
Capital invested by funds: $2.5B → $2.24B (-$265M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$28.3M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$25.1M |
| 3 |
Jennison Associates
New York
|
+$17.6M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$16.7M |
| 5 |
Bank of New York Mellon
New York
|
+$14.2M |
Top Sellers
| 1 |
DCP
D1 Capital Partners
New York
|
-$226M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$95M |
| 3 |
BlackRock
New York
|
-$14.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$10.7M |
| 5 |
GH
GAM Holding
Zurich,
Switzerland
|
-$9.6M |
OM Hedge Fund Activity: Q4 2021 in Review
156 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2021, worth a combined $2.24B — down 11% from $2.5B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new OM positions and 18 closed out — a net gain of 16 holders — while 61 added to existing stakes and 33 trimmed.
The largest buyer was Fiera Capital (Canada), opening a new position worth an estimated $28.3M. The largest seller was D1 Capital Partners, exiting entirely with an estimated $226M sold.
- 156 institutional investors held Outset Medical (OM) as of Q4 2021, up from 142 in Q3 2021.
- Funds reported $2.24B of Outset Medical stock for Q4 2021, down 11% quarter-over-quarter.
- 34 funds opened new Outset Medical positions in Q4 2021 and 18 closed out, a net change of +16 holders.
- The largest Outset Medical buyer in Q4 2021 was Fiera Capital (Canada), an estimated $28.3M added.
- The largest Outset Medical seller in Q4 2021 was D1 Capital Partners, an estimated $226M sold.
Based on aggregated 13F filings for Q4 2021.